Cellectis - ADR
CLLS
Get informed when a big investor buys or sells
+ FollowMarket Cap$284.18M
Close$
$-1.33
140.4% downside
Current Fair Value
140.4% downsideOvervalued by 140.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $284.18 Million |
|---|---|
| Enterprise Value | $450.85 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.68 |
| Beta | 2.75 |
| Outstanding Shares | 100,527,276 |
Return
| Return on Equity | -113.16% |
|---|---|
| Return on Assets | -23.45% |
| Return on Invested Capital | -34.73% |
Valuation & Multiples
| P/E Ratio | -4.14 |
|---|---|
| PEG | 251.5 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.6 |
| Enterprise Value to EBIT | -8.39 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 3.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$11.04 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$12.09 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.23%▼ 0.29% |
|---|---|
| Total Invested | $32.52M▼ 36.30% |
| Investors Holding | 33▼ 1.00% |
ESG Score
No data
About Cellectis
CEO: Andre Choulika